Amendment No. 2 to Arena Pharmaceuticals, Inc. Amended and Restated Severance Benefit Plan

Contract Categories: Human Resources › Severance Agreements
Summary

This amendment adds Vincent E. Aurentz to Arena Pharmaceuticals, Inc.'s Severance Benefit Plan, granting him an 18-month severance period. The amendment is effective as of August 15, 2016, and is executed by the company's President and CEO. The agreement outlines the updated eligibility for severance benefits under the company's existing plan.

Read More Arrow
EX-10.2 3 arna-ex102_176.htm EX-10.2 arna-ex102_176.htm

 

Exhibit 10.2

AMENDMENT NO. 2 TO

ARENA PHARMACEUTICALS, INC.

AMENDED AND RESTATED SEVERANCE BENEFIT PLAN

The Arena Pharmaceuticals, Inc., Amended and Restated Severance Benefit Plan, dated May 9, 2016, as amended (the “Plan”), is hereby further amended as of August 15, 2016, by this Amendment No. 2 as follows:

Vincent E. Aurentz is hereby added to Exhibit A of the Plan, with a Severance Period of 18 months.

To record the adoption of this Amendment No. 2, Arena Pharmaceuticals, Inc., has caused its duly authorized officer to execute the same this 15th day of August 2016.

 

 

Arena Pharmaceuticals, Inc.

 

/s/ Amit Munshi

Amit Munshi

President and Chief Executive Officer